SlideShare a Scribd company logo
PRESENTED BY : N/CDT. PRIYANKA GIRI
IV YEAR BASIC B.SC NURSING
GUIDED BY : LT. COL. MEENAKSHI MANOCHA
ASSOCIATE PROFESSOR
 Universal Immunization Program is
a vaccination program launched by
the Government of India in 1985.
 It became a part of Child Survival and Safe
Motherhood Program in 1992 and is currently
one of the key areas under National Rural
Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
 Tuberculosis
 Diphtheria
 Pertussis
 Tetanus,
 Poliomyelitis,
 Measles,
 Hepatitis B,
 Diarrhea,
 Japanese-Encephalitis,
 Rubella,
 Pneumonia
 Pneumococcal diseases
UNDER RCH I
The most common constraints of immunization
success are
- Non uniform coverage
- Poor implementation
- Poor monitoring
- High dropouts
- Over reporting
- Poor injection safety
- Reorientation of staff being not carried out
- Cold chain replacement plan not made
- Vacancy of staff at field level not filled
- Poor surveillance of vaccine preventable dieses
- Poor vaccine logistics
- Poor maintenance of equipment
- Extra ordinary emphasis on polio vaccine
 Under RCH II
The six goals and their respective objectives
with strategies to achieve these objectives are
summaries in following slides.
 Districts will provide efficient and safe
immunization to all infants and pregnant women.
Objectives
 Regular quality immunization sessions are
planned and held.
 Adequate trained staff are empowered to
provide quality immunization services.
 An annually upgraded cold chain inventory
according to level of network, in order to
maintain a functional status of 90%.
 An efficient vaccine and injection equipment
management and logistic system to forecast and
deliver adequate supplies of vaccines in timely
manner.
 The implementation of safe injection practices
and waste disposal.
Strategies
 Strategies include coordination between national
and state level.
 Printing and supply of national operation
guideline.
 Strengthening of supervision.
 Prioritization of under served population within
districts.
 Strengthening & training of all categories of staff.
 Management of cold chain.
 Procurement installation of cold chain
equipment.
 Proper inventory management.
 Cold chain maintenance and repair.
 Timely supply of vaccine.
 Phased introduction of auto disposal syringes
and safety boxes.
 Contribute to global polio eradication, measles
mortality reduction and neonatal tetanus
elimination.
Objectives
 Polio eradication certification by 2007.
 Elimination of neonatal tetanus by 2009.
 Reduction measles mortality by 2/3 compared to
2000 estimates, by 2010.
 Achieve and maintain 70% coverage of two
doses of vitamin A to children < 3 years.
Strategies
 Strategies include routine immunization for
polio.
 Supplementary immunization campaigns.
 AFP virological surveillance.
 Strengthening service delivery.
 Increasing reporting and action on cases.
 Data analysis.
 Safe delivery practices.
 Targeting supplementary immunization activities.
 Strengthening measles vaccination and
surveillance and response to the outbreaks.
 The UIP will have sufficient and sustainable
funding with established adequate, accountable
and efficient fund flows.
Objectives
 Adequate and reliable financial resources and
national, state and local levels for UIP to achieve
goals and objectives.
 Political commitments for adequate annual
funding at all levels.
Strategies
 Strengthening national financial planning and
building partnerships.
 Sustain demand and reduce social barriers to
access immunization services.
Objectives
 Widespread support by families & communities.
 All eligible children and pregnant women are
immunized.
 High level political and administrative support for
immunization.
Strategies
 Include coverage with print, electronic media
and improve interpersonal communication.
 Accelerated introduction of licensed new and
under utilized vaccines against diseases with
significant mortality and morbidity in India.
Objectives
 Institutional mechanisms in place to adequately
obtained, review and utilize information for
deciding on introduction of new and under
utilized vaccines.
 Review need for MMR or MR vaccine in India’s
immunization program.
 Review need for introduction of Japanese
encephalitis vaccine.
 A phased introduction of Hepatitis B vaccine.
Strategies
 Strategies include improve coordination
between MoHFW, research institute, NRI and
development partners, disease burden study,
surveillance and training.
 To monitor and use accurate, complete and
timely data on vaccine preventable disease,
AEFIs, antigen coverage and drop out rates by
districts.
Objectives
 Institutionalize surveillance of VPD’s and early
detection of any outbreaks.
 Strengthened vaccine quality and injection
safety by developing monitoring system.
 An effective, efficient, complete and timely
immunization, local recording and area
monitoring system.
Measles is highly contagious viral disease,
occur in over crowded area and coverage of
measles vaccine is poor.
 These areas needed special vaccination drive
which was initiated by UNICEF in 1998 covering
13 cities and in 1999-2000, 50 more cities were
also covered.
 Now the main focus is on covering all
unprotected children upto 3 years.
 Age of giving MMR vaccine is 15 months.
 MMR can be given till 5 years of age under UIP.
 Greece and Bulgaria indicates low coverage of
vaccination in children due to change in national
immunization schedule.
 Study highlights that there is need of constant
supervision of national immunization program
and repeat dose of MMR in adolescents or
youth.
 In some places like Delhi the measles, mumps
and rubella (MMR) vaccine has been introduced
in the program.
 It is given at 15 month of age in a dose of 0.5ml
IM/SC.
 If measles is not received by the child till 12
months of age MMR vaccine can be given.
 MMR can be given till 5 years of age under the
program.
 Neonatal tetanus is a common problem in many
developing countries.
 In some instances NNT is responsible for >50%
of neonatal deaths which, themselves, may
account for >50% of all infants deaths.
 It is estimated that about 3,00,000 cases NNT
occurred worldwide each year, of which
approximately 2/3 died.
 In 1990 neonatal tetanus accounted for almost
80,000 deaths. India was finally declared free of
maternal and neonatal tetanus on May 15, 2015
by WHO.
 Scientifically this disease has been eliminated
by immunizing all women in reproductive age
group with tetanus toxoid.
Elimination of NNT is done by-
 Coverage of all pregnant women with two doses
of tetanus toxoid
 Extensive IEC efforts to promote clean
deliveries;
 Five cleans-clean hands, clean surface, clean
blade, clean stump, clean cord tie.
 Providing disposable delivery kits
 Community based surveillance of neonatal
deaths and investigation and control measures
in case of neonatal deaths.
 Neonatal tetanus elimination is defined as less
than 1 case of neonatal tetanus per 1000 live
births in every district.
 Recommendation after validation of NTT
elimination;
 Maintain High TT vaccination coverage to
pregnant women.
 Improve institutional delivery practices
 Strengthen surveillance of NNT.
 Hepatitis B is viral infection that attacks the liver
and can cause both acute and chronic liver
disease.
 The virus is transmitted through contact with
blood or other body Fluids of an infected person.
 It is a major Global health problem and the most
serious type of viral hepatitis.
 About 2 billion people worldwide have been
infected with virus and about 350 million live
with chronic infection.
 An estimated 6 lakh persons die each year due
to acute or chronic consequences of Hepatitis B.
 The Hepatitis virus is 50 to 100 times more
infectious than HIV.
 Hepatitis B virus is an important occupational
hazard for health workers.
 India is in an intermediate endemic state with
prevalence of 2-7 %.
 Hepatitis B is preventable with a safe and
effective vaccine. A vaccine against Hepatitis B
have been available since 1982. Hepatitis B
vaccine is 95 % effective in preventing HBV
infection and its chronic consequences.
 First dose of hepatitis B may be given at birth or
within 48 hours of delivery in institutional
deliveries. Otherwise three doses are given
together with OPV and DPT doses in the dose of
0.5 ml intramuscularly.
 Typhoid is a major public health problem in
India.
 Causes heavy morbidity and mortality.
 Typhoid vaccine has been introduced in Delhi by
the Directorate of safeguards all children below
5 years of age.
 Vaccine can be given to the children above 2
years of age till 5 years of age IM.
 Approximately 410000 of under 5 deaths in India
are due to pneumonia out of which an estimated
70000 are caused by Haemophilus Influenzae
Type B.
 Data from some developing countries such as
Bangladesh, Chile and Malawi suggested that it
is a cause of over 20% of life threatening
childhood pneumonia.
 Small scale studies from India have documented
case fatality rate of HIB Meningitis as 11 %, and
about 30% of survivors suffer from major
disabilities.
 This is why HIB vaccine introduction in National
immunization Program (NIP) of India has been
done.
 The Pentavalent vaccine combines 5 different
vaccine in one injection to protect at least five
diseases;
I. Haemophilus Influenzae Type B diseases
II. Diphtheria
III. Pertussis
IV. Tetanus
V. Hepatitis B.
 Children immunized with the 5-in-1 vaccine don’t
need to be vaccinated separately with the DPT
or Hepatitis B vaccine
 All children during their first year of age should
receive 3 doses of pentavalent vaccine with an
interval of at least 4 weeks between the doses.
 However children who have already started
immunization with DPT and hepatitis B have to
complete their vaccination with DPT and
hepatitis B only, they are not to be given
pentavalent vaccine.
 Vaccination with pentavalent must be completed
within 2 years of age if the child starts before
one year of age.
 Children under 6 weeks of age, over 5 years,
teenagers and adults should not be given
pentavalent vaccine because of the DPT
component.
 The "cold-chain" is a system of storage and
transport of vaccine at low temperature from the
manufacturer to the actual vaccination site.
 In other words the success of national
immunization program is highly dependant on
supply chain system for delivery of vaccines and
equipments, with a functional system that meets
6 rights of supply chain;
-The right vaccine in right quantity at the right
place at the right time in the right condition
and at the right cost.
 Among the vaccines, Polio is the most sensitive
to heat requiring storage at -20 degree
centigrade.
 Vaccines must be stored in the freezer
compartment are; Polio and Measles.
 Vaccine which must be stored in cold part but
never allowed to freeze are "T Series" vaccines
(DPT, Tetanus toxoid, DT) Hepatitis B, BCG and
Diluents.
 In general all vaccine must be stored under the
conditions recommended by the manufacturer in
the literature accompanying the vaccine,
otherwise they may become denatured and
totally ineffective.
 Vaccine must be protected from sunlight and
antiseptics.
 At the health centre, most vaccines can be
stored up to 5 weeks if the refrigerator
temperature is strictly kept between 2 to 8
centigrade.
 Do not keep any used vials in the cold chain.
 Return the unused vaccine vial from the session
site to the PHC on the same day in the cold
chain through alternative vaccine delivery.
 Keep the box labeled "returned unused" in the
ILR for all unused vaccines that can be used in
the subsequent session, but discard vaccines
that have been returned unopened more than 3
times.
 Walk in cold room (WIC): located at regional
level. Store vaccine for 3 months. Serve 4 to 5
districts.
 Deep freezer: supplied to all districts (large) and PHC
(small) to store vaccines.
 Temperature maintain between -15 degree centigrade to
-25 degree centigrade.
 In case of power failure these freezers can maintain the
cabinet temperature for 18 to 22 hours.
 Ice Lined Refrigerator (ILR) : ILR are kept at
the PHC (small) and District level (large).
 The cabinet temperature is maintained at + 2
degree centigrade to + 8 degree centigrade. At
the PHC level, ILR are used for storing all UIP
vaccine. ILR are lined with tubes or Ice packs
filled with water which freezes and keeps the
internal temperature at a safe level.
 All vaccines must be kept in the basket of the
ILR along with the diluents.
A Dial thermometer should be kept in the ILR
and temperature recorded twice a day. At the
time of defrosting the vaccines are shifted to the
cold boxes containing required number of frozen
ice packs.
 COLD BOXES: Cold boxes are supplied to all
peripheral centres.
 These are used mainly for transportation of the vaccines.
 Before the vaccines are place in the cold boxes,
fully frozen ice packs are placed at the bottom
and sides.
 The vaccines are first kept in cartons or
Polythene bags.
 The vials of DPT, DT, TT vaccines and diluents
should not be placed in direct contact with the
frozen ice packs.
 Vaccine Carrier: Vaccine Carriers are used to
carry small quantities of vaccines (16 to 20 vials)
for the out of reach session.
 4 fully frozen ice packs are used for lining the
sides, and the vials of DPT, DT, TT and diluents
should not be placed in direct contact with the
frozen ice packs.
 The carriers should be closed tightly.
 Day Carriers: Day Carriers are used to carry
small quantities of vaccines (6 to 8) vials to a
nearby session.
 It is only used for few hours period.
 Ice Packs: The ice pack contain water and no salt
should be added to it.
 The water should be filled up to the level mark on the
side.
 If there is any leakage such ice pack should be
discarded.
The shake test to determine whether vaccine
has been frozen
 DPT, hepatitis B and Tetanus toxoid vaccines
can be damaged by freezing. You can find out
whether this has occurred by using the shake
test.
1. Take two DPT vials, one that you think might
have been frozen and another from the same
manufacturer which you KNOW has never
been frozen.
2. Shake both vials.
3. Look at the vaccine inside the two vials.
4. Let the sediment settle for 15-30 minutes.
5. Again look at the vaccine inside the two vials.
(see image)
 Vaccines are not stored at the sub-centre level
and must be supplied on the day of use.
 PHC must not hold more than 1 month's stock.
 Immunization must be carried out in a shade.
 The vaccines (OPV and Measles) must be kept
on an ice pack or in a cup of ice during the
vaccination session.
 No direct sunlight should fall on them.
 OPV sample should be sent with fully frozen ice
packs and rush to the assign laboratory for the
potency test.
 Measles vaccine should be used within 4 hours
of reconstitution. Similarly BCG should not be
used after 3 hours of reconstitution.
 Good disease surveillance.
 No pathogen variations.
 Potent vaccine.
 Adequate development and/or procurement of
vaccines.
 Appropriate and acceptable choice of
Technologies.
 Universal vaccination (even among childhood
vaccines).
 Adequate logistics, cost benefit analyses and
resource mobilization.
 Immunization sessions are not being held
regularly in the community.
 Inadequate mobility of the health worker and the
supervisory staff at district and state level.
 Problem of delivery of vaccines and drugs to
outreach session's site.
 In urban areas lack of adequate health
infrastructure.
 Lack of trained manpower for vaccination.
 Impact of rumors of vaccine adverse events or
deaths.
 Pulse Polio is an immunization campaign
established by the government of India to
eliminate poliomyelitis (polio) in India by
vaccinating all children under the age of five
years against the polio virus. The project fights
poliomyelitis through a large-scale pulse
vaccination program and monitoring for polio
cases.
 In India, vaccination against polio started in
1978 with Expanded Program on Immunization
(EPI). By 1984, it covered around 40% of
infants, giving three doses of OPV to each.
 In 1985, the UIP was launched to cover all the
districts of the country. UIP became a part of
child survival and safe motherhood program
(CSSM) in 1992 and Reproductive and Child
Health Program (RCH) in 1997. This program
led to a significant increase in coverage, up to
95%.
 In 1995, following the Global Polio Eradication
Initiative of the World Health Organization
(1988), India launched Pulse Polio immunization
program with Universal Immunization Program
which aimed at 100% coverage.
 Routine immunization : Immunize every child
age <1 year with at least 4 doses of
OPV through UIP.
 National immunization days (NIDs)/Pulse Polio
Immunization (PPI) program/Sub-National
Immunization days(SNIDs) : Conducted by
giving additional doses of OPV, 4 to 6 weeks
apart to every child age less than 5 years.
 Intensification of the pulse polio immunization
program has been done by adding additional
rounds at fixed booths followed by house to
house "search and vaccinate" component.
 National immunization day: In India transmission
of polio has been fluctuating so it has been
decided that there is a need to make extra
efforts to reach the unreached during pulse polio
immunization days. for that reason intensified
pulse polio immunization was proposed and just
after the national immunization day (Polio
Ravivaar ).
 Immunization team would visit house to house
with a vaccine to check whether the child has
received pulse polio vaccine and if not then child
must be given a dose of that time only.
 Surveillance of acute flaccid paralysis AFP: to
identify all reservoirs of wild polio virus
transmission surveillance of AFP has been
started. AFP is now defined as "any child is less
than 15 years of age who have sudden onset of
flaccid paralysis or paralytic illness in a person of
any age when polio suspected."
 Setting up of booths in all parts of the country.
 Initializing walk-in cold rooms, freezer rooms,
deep freezers, ice-lined refrigerators and cold
boxes for a steady supply of vaccine to booths.
 Arranging employees, volunteers, and vaccines.
 Ensuring vaccine vial monitor on each
vaccine vial.
 Immunizing children with OPV on national
immunization days.
 Identifying missing children from immunization
process.
 Surveillance of efficacy.
 Publicity was extensive and included replacing
the national telecoms' authority ringtone with a
vaccination day awareness message, posters,
TV and cinema spots, parades, rallies, and one-
to-one communication from volunteers.
Vaccination booths were set up, with a house-to-
house campaign for remote communities.
Universal Immunization Program
Universal Immunization Program
Universal Immunization Program
Universal Immunization Program

More Related Content

What's hot

National urban health mission
National urban health missionNational urban health mission
National urban health mission
Namita Batra
 
Pulse polio programme.pptx
Pulse polio programme.pptxPulse polio programme.pptx
Pulse polio programme.pptx
Easy Concept
 
Primary health center
Primary health centerPrimary health center
Primary health center
Vikas Ghadge
 
RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
Dr Shubhangi (Kshirsagar) Hedau
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
Dr Lipilekha Patnaik
 
Pulse polio immunizaton program
Pulse polio immunizaton programPulse polio immunizaton program
Pulse polio immunizaton program
Jobin Jacob
 
National tuberculosis control programme
National tuberculosis control programmeNational tuberculosis control programme
National tuberculosis control programme
Soumya Ranjan Parida
 
National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
Kavya .
 
Universal Immunization Program
Universal Immunization ProgramUniversal Immunization Program
Universal Immunization Program
Sravani Ambati
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
Dr Lipilekha Patnaik
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017
Annu verma
 
National Urban Health Mission
National Urban Health MissionNational Urban Health Mission
National Urban Health Mission
Dr Christa Maria Joel MBBS MPH MRSPH
 
Pulse polio programme.pptx
Pulse polio programme.pptxPulse polio programme.pptx
Pulse polio programme.pptx
Sneha Gaurkar
 
National family welfare programme
National family welfare programmeNational family welfare programme
National family welfare programme
Mahesh Chand
 
National AIDS control programme ppt
National AIDS control programme pptNational AIDS control programme ppt
National AIDS control programme ppt
KomalSingh811671
 
Primary Health Centre
Primary Health CentrePrimary Health Centre
Primary Health Centre
Annu verma
 
National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
Sneha Gaurkar
 
National leprosey eradication program
National leprosey eradication programNational leprosey eradication program
National leprosey eradication program
pramod kumar
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
Harsh Rastogi
 

What's hot (20)

National urban health mission
National urban health missionNational urban health mission
National urban health mission
 
Pulse polio programme.pptx
Pulse polio programme.pptxPulse polio programme.pptx
Pulse polio programme.pptx
 
Primary health center
Primary health centerPrimary health center
Primary health center
 
RNTCP programme.pdf
RNTCP programme.pdfRNTCP programme.pdf
RNTCP programme.pdf
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
 
Pulse polio immunizaton program
Pulse polio immunizaton programPulse polio immunizaton program
Pulse polio immunizaton program
 
National tuberculosis control programme
National tuberculosis control programmeNational tuberculosis control programme
National tuberculosis control programme
 
National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
 
Universal Immunization Program
Universal Immunization ProgramUniversal Immunization Program
Universal Immunization Program
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
 
Universal Immunization Program 2017
Universal Immunization Program 2017Universal Immunization Program 2017
Universal Immunization Program 2017
 
National Urban Health Mission
National Urban Health MissionNational Urban Health Mission
National Urban Health Mission
 
Pulse polio programme.pptx
Pulse polio programme.pptxPulse polio programme.pptx
Pulse polio programme.pptx
 
National family welfare programme
National family welfare programmeNational family welfare programme
National family welfare programme
 
National AIDS control programme ppt
National AIDS control programme pptNational AIDS control programme ppt
National AIDS control programme ppt
 
Primary Health Centre
Primary Health CentrePrimary Health Centre
Primary Health Centre
 
National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)National Leprosy Eradication Programme (NLEP)
National Leprosy Eradication Programme (NLEP)
 
National leprosey eradication program
National leprosey eradication programNational leprosey eradication program
National leprosey eradication program
 
Nuhm
NuhmNuhm
Nuhm
 
National AIDS Control Programme NACP
National AIDS Control Programme NACPNational AIDS Control Programme NACP
National AIDS Control Programme NACP
 

Similar to Universal Immunization Program

Importance of immunization
Importance of immunizationImportance of immunization
Importance of immunization
Shahid Imran Khan
 
National Immunization Program of Nepal from POSDCORB Perspectives
National Immunization Program of Nepal from POSDCORB PerspectivesNational Immunization Program of Nepal from POSDCORB Perspectives
National Immunization Program of Nepal from POSDCORB Perspectives
Mohammad Aslam Shaiekh
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
JenEugenio2
 
NATIONAL IMMUNISATION PROGRAMME ...
NATIONAL IMMUNISATION PROGRAMME ...NATIONAL IMMUNISATION PROGRAMME ...
NATIONAL IMMUNISATION PROGRAMME ...
amol askar
 
Exhibition on Family Planning
Exhibition on Family PlanningExhibition on Family Planning
Exhibition on Family Planning
Mohammad Aslam Shaiekh
 
National immunization programme
National immunization programmeNational immunization programme
National immunization programme
Anju sapkota
 
EPI
EPIEPI
EPI - Copy.ppt
EPI - Copy.pptEPI - Copy.ppt
EPI - Copy.ppt
Sana Murtaza
 
Future generation vaccines
Future generation vaccinesFuture generation vaccines
Future generation vaccines
Dr.Santosh Kadle
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
Sapna Desai
 
Pulse Polio Program by Mujahid
Pulse Polio Program by MujahidPulse Polio Program by Mujahid
Pulse Polio Program by Mujahid
HOME
 
Measles
MeaslesMeasles
Measlesjehlam
 
universal immunization program.pptx
universal immunization program.pptxuniversal immunization program.pptx
universal immunization program.pptx
bharatibakde1
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
AnthonyMatu1
 
175678193 3
175678193 3175678193 3
175678193 3
homeworkping9
 
1Global Vaccination (attach this please with the previou.docx
1Global Vaccination (attach this please with the previou.docx1Global Vaccination (attach this please with the previou.docx
1Global Vaccination (attach this please with the previou.docx
felicidaddinwoodie
 
Vaccination in women form womb to tomb
Vaccination in women form womb to tombVaccination in women form womb to tomb
Vaccination in women form womb to tomb
Jaideepfogsi
 
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVADr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
NARENDRA MALHOTRA
 

Similar to Universal Immunization Program (20)

Importance of immunization
Importance of immunizationImportance of immunization
Importance of immunization
 
National Immunization Program of Nepal from POSDCORB Perspectives
National Immunization Program of Nepal from POSDCORB PerspectivesNational Immunization Program of Nepal from POSDCORB Perspectives
National Immunization Program of Nepal from POSDCORB Perspectives
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
NIP PPT.pptx
NIP PPT.pptxNIP PPT.pptx
NIP PPT.pptx
 
NATIONAL IMMUNISATION PROGRAMME ...
NATIONAL IMMUNISATION PROGRAMME ...NATIONAL IMMUNISATION PROGRAMME ...
NATIONAL IMMUNISATION PROGRAMME ...
 
Exhibition on Family Planning
Exhibition on Family PlanningExhibition on Family Planning
Exhibition on Family Planning
 
National immunization programme
National immunization programmeNational immunization programme
National immunization programme
 
EPI
EPIEPI
EPI
 
EPI - Copy.ppt
EPI - Copy.pptEPI - Copy.ppt
EPI - Copy.ppt
 
Future generation vaccines
Future generation vaccinesFuture generation vaccines
Future generation vaccines
 
Universal immunization programme
Universal immunization programmeUniversal immunization programme
Universal immunization programme
 
Pulse Polio Program by Mujahid
Pulse Polio Program by MujahidPulse Polio Program by Mujahid
Pulse Polio Program by Mujahid
 
Measles
MeaslesMeasles
Measles
 
universal immunization program.pptx
universal immunization program.pptxuniversal immunization program.pptx
universal immunization program.pptx
 
Child health
Child healthChild health
Child health
 
immunization dnm4 lesson 3.pptx
immunization                    dnm4 lesson 3.pptximmunization                    dnm4 lesson 3.pptx
immunization dnm4 lesson 3.pptx
 
175678193 3
175678193 3175678193 3
175678193 3
 
1Global Vaccination (attach this please with the previou.docx
1Global Vaccination (attach this please with the previou.docx1Global Vaccination (attach this please with the previou.docx
1Global Vaccination (attach this please with the previou.docx
 
Vaccination in women form womb to tomb
Vaccination in women form womb to tombVaccination in women form womb to tomb
Vaccination in women form womb to tomb
 
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVADr girija wagh   vaccination in women form womb to tomb ADBHUT MATRUTVA
Dr girija wagh vaccination in women form womb to tomb ADBHUT MATRUTVA
 

Recently uploaded

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

Universal Immunization Program

  • 1. PRESENTED BY : N/CDT. PRIYANKA GIRI IV YEAR BASIC B.SC NURSING GUIDED BY : LT. COL. MEENAKSHI MANOCHA ASSOCIATE PROFESSOR
  • 2.  Universal Immunization Program is a vaccination program launched by the Government of India in 1985.  It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
  • 3. Program consists of vaccination for 12 diseases -  Tuberculosis  Diphtheria  Pertussis  Tetanus,  Poliomyelitis,  Measles,  Hepatitis B,  Diarrhea,  Japanese-Encephalitis,  Rubella,  Pneumonia  Pneumococcal diseases
  • 4.
  • 5. UNDER RCH I The most common constraints of immunization success are - Non uniform coverage - Poor implementation - Poor monitoring - High dropouts - Over reporting - Poor injection safety
  • 6. - Reorientation of staff being not carried out - Cold chain replacement plan not made - Vacancy of staff at field level not filled - Poor surveillance of vaccine preventable dieses - Poor vaccine logistics - Poor maintenance of equipment - Extra ordinary emphasis on polio vaccine
  • 7.  Under RCH II The six goals and their respective objectives with strategies to achieve these objectives are summaries in following slides.
  • 8.  Districts will provide efficient and safe immunization to all infants and pregnant women. Objectives  Regular quality immunization sessions are planned and held.  Adequate trained staff are empowered to provide quality immunization services.
  • 9.  An annually upgraded cold chain inventory according to level of network, in order to maintain a functional status of 90%.  An efficient vaccine and injection equipment management and logistic system to forecast and deliver adequate supplies of vaccines in timely manner.  The implementation of safe injection practices and waste disposal.
  • 10. Strategies  Strategies include coordination between national and state level.  Printing and supply of national operation guideline.  Strengthening of supervision.  Prioritization of under served population within districts.  Strengthening & training of all categories of staff.
  • 11.  Management of cold chain.  Procurement installation of cold chain equipment.  Proper inventory management.  Cold chain maintenance and repair.  Timely supply of vaccine.  Phased introduction of auto disposal syringes and safety boxes.
  • 12.  Contribute to global polio eradication, measles mortality reduction and neonatal tetanus elimination. Objectives  Polio eradication certification by 2007.  Elimination of neonatal tetanus by 2009.  Reduction measles mortality by 2/3 compared to 2000 estimates, by 2010.  Achieve and maintain 70% coverage of two doses of vitamin A to children < 3 years.
  • 13. Strategies  Strategies include routine immunization for polio.  Supplementary immunization campaigns.  AFP virological surveillance.  Strengthening service delivery.  Increasing reporting and action on cases.  Data analysis.  Safe delivery practices.  Targeting supplementary immunization activities.  Strengthening measles vaccination and surveillance and response to the outbreaks.
  • 14.  The UIP will have sufficient and sustainable funding with established adequate, accountable and efficient fund flows. Objectives  Adequate and reliable financial resources and national, state and local levels for UIP to achieve goals and objectives.  Political commitments for adequate annual funding at all levels. Strategies  Strengthening national financial planning and building partnerships.
  • 15.  Sustain demand and reduce social barriers to access immunization services. Objectives  Widespread support by families & communities.  All eligible children and pregnant women are immunized.  High level political and administrative support for immunization. Strategies  Include coverage with print, electronic media and improve interpersonal communication.
  • 16.  Accelerated introduction of licensed new and under utilized vaccines against diseases with significant mortality and morbidity in India. Objectives  Institutional mechanisms in place to adequately obtained, review and utilize information for deciding on introduction of new and under utilized vaccines.  Review need for MMR or MR vaccine in India’s immunization program.
  • 17.  Review need for introduction of Japanese encephalitis vaccine.  A phased introduction of Hepatitis B vaccine. Strategies  Strategies include improve coordination between MoHFW, research institute, NRI and development partners, disease burden study, surveillance and training.
  • 18.  To monitor and use accurate, complete and timely data on vaccine preventable disease, AEFIs, antigen coverage and drop out rates by districts. Objectives  Institutionalize surveillance of VPD’s and early detection of any outbreaks.
  • 19.  Strengthened vaccine quality and injection safety by developing monitoring system.  An effective, efficient, complete and timely immunization, local recording and area monitoring system.
  • 20. Measles is highly contagious viral disease, occur in over crowded area and coverage of measles vaccine is poor.  These areas needed special vaccination drive which was initiated by UNICEF in 1998 covering 13 cities and in 1999-2000, 50 more cities were also covered.  Now the main focus is on covering all unprotected children upto 3 years.  Age of giving MMR vaccine is 15 months.
  • 21.  MMR can be given till 5 years of age under UIP.  Greece and Bulgaria indicates low coverage of vaccination in children due to change in national immunization schedule.  Study highlights that there is need of constant supervision of national immunization program and repeat dose of MMR in adolescents or youth.
  • 22.
  • 23.  In some places like Delhi the measles, mumps and rubella (MMR) vaccine has been introduced in the program.  It is given at 15 month of age in a dose of 0.5ml IM/SC.  If measles is not received by the child till 12 months of age MMR vaccine can be given.  MMR can be given till 5 years of age under the program.
  • 24.  Neonatal tetanus is a common problem in many developing countries.  In some instances NNT is responsible for >50% of neonatal deaths which, themselves, may account for >50% of all infants deaths.  It is estimated that about 3,00,000 cases NNT occurred worldwide each year, of which approximately 2/3 died.
  • 25.  In 1990 neonatal tetanus accounted for almost 80,000 deaths. India was finally declared free of maternal and neonatal tetanus on May 15, 2015 by WHO.  Scientifically this disease has been eliminated by immunizing all women in reproductive age group with tetanus toxoid. Elimination of NNT is done by-  Coverage of all pregnant women with two doses of tetanus toxoid
  • 26.  Extensive IEC efforts to promote clean deliveries;  Five cleans-clean hands, clean surface, clean blade, clean stump, clean cord tie.  Providing disposable delivery kits  Community based surveillance of neonatal deaths and investigation and control measures in case of neonatal deaths.
  • 27.  Neonatal tetanus elimination is defined as less than 1 case of neonatal tetanus per 1000 live births in every district.  Recommendation after validation of NTT elimination;  Maintain High TT vaccination coverage to pregnant women.  Improve institutional delivery practices  Strengthen surveillance of NNT.
  • 28.  Hepatitis B is viral infection that attacks the liver and can cause both acute and chronic liver disease.  The virus is transmitted through contact with blood or other body Fluids of an infected person.  It is a major Global health problem and the most serious type of viral hepatitis.  About 2 billion people worldwide have been infected with virus and about 350 million live with chronic infection.
  • 29.
  • 30.  An estimated 6 lakh persons die each year due to acute or chronic consequences of Hepatitis B.  The Hepatitis virus is 50 to 100 times more infectious than HIV.  Hepatitis B virus is an important occupational hazard for health workers.  India is in an intermediate endemic state with prevalence of 2-7 %.  Hepatitis B is preventable with a safe and effective vaccine. A vaccine against Hepatitis B have been available since 1982. Hepatitis B vaccine is 95 % effective in preventing HBV infection and its chronic consequences.
  • 31.  First dose of hepatitis B may be given at birth or within 48 hours of delivery in institutional deliveries. Otherwise three doses are given together with OPV and DPT doses in the dose of 0.5 ml intramuscularly.
  • 32.  Typhoid is a major public health problem in India.  Causes heavy morbidity and mortality.  Typhoid vaccine has been introduced in Delhi by the Directorate of safeguards all children below 5 years of age.  Vaccine can be given to the children above 2 years of age till 5 years of age IM.
  • 33.  Approximately 410000 of under 5 deaths in India are due to pneumonia out of which an estimated 70000 are caused by Haemophilus Influenzae Type B.  Data from some developing countries such as Bangladesh, Chile and Malawi suggested that it is a cause of over 20% of life threatening childhood pneumonia.  Small scale studies from India have documented case fatality rate of HIB Meningitis as 11 %, and about 30% of survivors suffer from major disabilities.
  • 34.
  • 35.  This is why HIB vaccine introduction in National immunization Program (NIP) of India has been done.  The Pentavalent vaccine combines 5 different vaccine in one injection to protect at least five diseases; I. Haemophilus Influenzae Type B diseases II. Diphtheria III. Pertussis IV. Tetanus V. Hepatitis B.
  • 36.  Children immunized with the 5-in-1 vaccine don’t need to be vaccinated separately with the DPT or Hepatitis B vaccine  All children during their first year of age should receive 3 doses of pentavalent vaccine with an interval of at least 4 weeks between the doses.  However children who have already started immunization with DPT and hepatitis B have to complete their vaccination with DPT and hepatitis B only, they are not to be given pentavalent vaccine.
  • 37.  Vaccination with pentavalent must be completed within 2 years of age if the child starts before one year of age.  Children under 6 weeks of age, over 5 years, teenagers and adults should not be given pentavalent vaccine because of the DPT component.
  • 38.  The "cold-chain" is a system of storage and transport of vaccine at low temperature from the manufacturer to the actual vaccination site.  In other words the success of national immunization program is highly dependant on supply chain system for delivery of vaccines and equipments, with a functional system that meets 6 rights of supply chain; -The right vaccine in right quantity at the right place at the right time in the right condition and at the right cost.
  • 39.  Among the vaccines, Polio is the most sensitive to heat requiring storage at -20 degree centigrade.  Vaccines must be stored in the freezer compartment are; Polio and Measles.  Vaccine which must be stored in cold part but never allowed to freeze are "T Series" vaccines (DPT, Tetanus toxoid, DT) Hepatitis B, BCG and Diluents.
  • 40.  In general all vaccine must be stored under the conditions recommended by the manufacturer in the literature accompanying the vaccine, otherwise they may become denatured and totally ineffective.  Vaccine must be protected from sunlight and antiseptics.  At the health centre, most vaccines can be stored up to 5 weeks if the refrigerator temperature is strictly kept between 2 to 8 centigrade.
  • 41.  Do not keep any used vials in the cold chain.  Return the unused vaccine vial from the session site to the PHC on the same day in the cold chain through alternative vaccine delivery.  Keep the box labeled "returned unused" in the ILR for all unused vaccines that can be used in the subsequent session, but discard vaccines that have been returned unopened more than 3 times.
  • 42.  Walk in cold room (WIC): located at regional level. Store vaccine for 3 months. Serve 4 to 5 districts.
  • 43.  Deep freezer: supplied to all districts (large) and PHC (small) to store vaccines.  Temperature maintain between -15 degree centigrade to -25 degree centigrade.  In case of power failure these freezers can maintain the cabinet temperature for 18 to 22 hours.
  • 44.  Ice Lined Refrigerator (ILR) : ILR are kept at the PHC (small) and District level (large).  The cabinet temperature is maintained at + 2 degree centigrade to + 8 degree centigrade. At the PHC level, ILR are used for storing all UIP vaccine. ILR are lined with tubes or Ice packs filled with water which freezes and keeps the internal temperature at a safe level.  All vaccines must be kept in the basket of the ILR along with the diluents.
  • 45. A Dial thermometer should be kept in the ILR and temperature recorded twice a day. At the time of defrosting the vaccines are shifted to the cold boxes containing required number of frozen ice packs.
  • 46.  COLD BOXES: Cold boxes are supplied to all peripheral centres.  These are used mainly for transportation of the vaccines.
  • 47.  Before the vaccines are place in the cold boxes, fully frozen ice packs are placed at the bottom and sides.  The vaccines are first kept in cartons or Polythene bags.  The vials of DPT, DT, TT vaccines and diluents should not be placed in direct contact with the frozen ice packs.
  • 48.  Vaccine Carrier: Vaccine Carriers are used to carry small quantities of vaccines (16 to 20 vials) for the out of reach session.  4 fully frozen ice packs are used for lining the sides, and the vials of DPT, DT, TT and diluents should not be placed in direct contact with the frozen ice packs.  The carriers should be closed tightly.
  • 49.  Day Carriers: Day Carriers are used to carry small quantities of vaccines (6 to 8) vials to a nearby session.  It is only used for few hours period.
  • 50.  Ice Packs: The ice pack contain water and no salt should be added to it.  The water should be filled up to the level mark on the side.  If there is any leakage such ice pack should be discarded.
  • 51.
  • 52. The shake test to determine whether vaccine has been frozen  DPT, hepatitis B and Tetanus toxoid vaccines can be damaged by freezing. You can find out whether this has occurred by using the shake test. 1. Take two DPT vials, one that you think might have been frozen and another from the same manufacturer which you KNOW has never been frozen.
  • 53. 2. Shake both vials. 3. Look at the vaccine inside the two vials. 4. Let the sediment settle for 15-30 minutes. 5. Again look at the vaccine inside the two vials. (see image)
  • 54.
  • 55.
  • 56.  Vaccines are not stored at the sub-centre level and must be supplied on the day of use.  PHC must not hold more than 1 month's stock.  Immunization must be carried out in a shade.  The vaccines (OPV and Measles) must be kept on an ice pack or in a cup of ice during the vaccination session.  No direct sunlight should fall on them.
  • 57.  OPV sample should be sent with fully frozen ice packs and rush to the assign laboratory for the potency test.  Measles vaccine should be used within 4 hours of reconstitution. Similarly BCG should not be used after 3 hours of reconstitution.
  • 58.  Good disease surveillance.  No pathogen variations.  Potent vaccine.  Adequate development and/or procurement of vaccines.  Appropriate and acceptable choice of Technologies.  Universal vaccination (even among childhood vaccines).  Adequate logistics, cost benefit analyses and resource mobilization.
  • 59.  Immunization sessions are not being held regularly in the community.  Inadequate mobility of the health worker and the supervisory staff at district and state level.  Problem of delivery of vaccines and drugs to outreach session's site.  In urban areas lack of adequate health infrastructure.  Lack of trained manpower for vaccination.  Impact of rumors of vaccine adverse events or deaths.
  • 60.  Pulse Polio is an immunization campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus. The project fights poliomyelitis through a large-scale pulse vaccination program and monitoring for polio cases.
  • 61.  In India, vaccination against polio started in 1978 with Expanded Program on Immunization (EPI). By 1984, it covered around 40% of infants, giving three doses of OPV to each.  In 1985, the UIP was launched to cover all the districts of the country. UIP became a part of child survival and safe motherhood program (CSSM) in 1992 and Reproductive and Child Health Program (RCH) in 1997. This program led to a significant increase in coverage, up to 95%.
  • 62.  In 1995, following the Global Polio Eradication Initiative of the World Health Organization (1988), India launched Pulse Polio immunization program with Universal Immunization Program which aimed at 100% coverage.
  • 63.  Routine immunization : Immunize every child age <1 year with at least 4 doses of OPV through UIP.  National immunization days (NIDs)/Pulse Polio Immunization (PPI) program/Sub-National Immunization days(SNIDs) : Conducted by giving additional doses of OPV, 4 to 6 weeks apart to every child age less than 5 years.  Intensification of the pulse polio immunization program has been done by adding additional rounds at fixed booths followed by house to house "search and vaccinate" component.
  • 64.  National immunization day: In India transmission of polio has been fluctuating so it has been decided that there is a need to make extra efforts to reach the unreached during pulse polio immunization days. for that reason intensified pulse polio immunization was proposed and just after the national immunization day (Polio Ravivaar ).  Immunization team would visit house to house with a vaccine to check whether the child has received pulse polio vaccine and if not then child must be given a dose of that time only.
  • 65.  Surveillance of acute flaccid paralysis AFP: to identify all reservoirs of wild polio virus transmission surveillance of AFP has been started. AFP is now defined as "any child is less than 15 years of age who have sudden onset of flaccid paralysis or paralytic illness in a person of any age when polio suspected."
  • 66.  Setting up of booths in all parts of the country.  Initializing walk-in cold rooms, freezer rooms, deep freezers, ice-lined refrigerators and cold boxes for a steady supply of vaccine to booths.  Arranging employees, volunteers, and vaccines.  Ensuring vaccine vial monitor on each vaccine vial.
  • 67.  Immunizing children with OPV on national immunization days.  Identifying missing children from immunization process.  Surveillance of efficacy.  Publicity was extensive and included replacing the national telecoms' authority ringtone with a vaccination day awareness message, posters, TV and cinema spots, parades, rallies, and one- to-one communication from volunteers. Vaccination booths were set up, with a house-to- house campaign for remote communities.